Accrelist Ltd. (SGX:QZG)
Singapore · Delayed Price · Currency is SGD 0.0620
-0.0040 (-6.06%)
At close: Jul 24, 2026
Accrelist Financials Overview
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 15.64 | 15.64 | 14.03 | 13.36 | 19.13 | 40.59 |
Revenue Growth | 28.08% | 11.48% | 5.01% | -30.15% | -52.88% | -73.17% |
Gross Profit Gross Profit Growth | 6.85 | 6.85 | 5.34 | 4.33 | 5.4 | 6.69 |
Operating Income Operating Income Growth | -3.68 | -3.68 | -8.28 | -6.11 | -5.03 | -5.06 |
Net Income Net Income Growth | -1.14 | -1.14 | -4.66 | -2.32 | -5.4 | -11.81 |
Earnings Per Share EPS Growth | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | -0.04 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Aesthetic Medical Services (AMS) Aesthetic Medical Services (AMS) Growth | 15.56 | 15.56 | 14.01 | 13.32 | 14.12 | 10.16 |
Others Others Growth | 0.08 | 0.08 | 0.02 | 0.04 | 0.02 | 0.01 |
Total Total Growth | 15.64 | 15.64 | 14.03 | 13.36 | 19.13 | 40.59 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5.21 | 5.21 | 7.7 | 10.03 | 15.39 | 12.3 |
Total Debt Total Debt Growth | 2.95 | 2.95 | 4.02 | 3.4 | 6.43 | 14.31 |
Net Cash (Debt) Net Cash Growth | 2.26 | 2.26 | 3.68 | 6.63 | 8.96 | -2.02 |
Net Cash Growth | -28.54% | -38.66% | -44.46% | -26.04% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | -0.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 0.51 | 0.51 | -2.71 | -7.95 | 1.5 | -0.26 |
Capital Expenditures CapEx Growth | -0.38 | -0.38 | -0.47 | -0.32 | -1.07 | -1.85 |
Free Cash Flow Free Cash Flow Growth | 0.13 | 0.13 | -3.18 | -8.27 | 0.43 | -2.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 43.80% | 43.80% | 38.09% | 32.43% | 28.25% | 16.49% |
Operating Margin | -23.54% | -23.54% | -59.02% | -45.71% | -26.28% | -12.46% |
Pretax Margin | -15.29% | -15.29% | -56.17% | -47.70% | -11.37% | -27.05% |
Profit Margin | -7.31% | -7.31% | -33.23% | -17.39% | -28.23% | -29.10% |
FCF Margin | 0.83% | 0.83% | -22.64% | -61.89% | 2.24% | -5.18% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 6.67 | 6.67 | 6.67 | 6.67 | 6.67 |
P/FCF Ratio | 154.30 | 129.41 | - | - | 45.31 | - |
PS Ratio | 1.27 | 1.07 | 0.87 | 1.15 | 1.02 | 0.37 |